Concepedia

Yangyiran Xie

YX

Statistics

Publications

13

Citations

536

H-Index

11

Active since

2018

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

Vanderbilt University

Sun Yat-sen University

First Hospital of Jilin University

Yangyiran Xie is an author at Johns Hopkins University specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2018–2024

13

Publications

13

Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness

Haiquan Lu, Yangyiran Xie, Thi My Linh Tran et al. · Journal of Clinical Investigation · 2020 · 162 citations · Full text

, , +17

Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment

Haiquan Lu, Thi My Linh Tran, Youngrok Park et al. · Cancer Research · 2018 · 90 citations · Full text

, , +17

HIF-1 recruits NANOG as a coactivator for TERT gene transcription in hypoxic breast cancer stem cells

Haiquan Lu, Yajing Lyu, Thi My Linh Tran et al. · Cell Reports · 2021 · 49 citations · Full text

, , +17

Dendrimer‐Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy

Hongkwan Cho, Siva P. Kambhampati, Michael J. Lai et al. · Advanced Therapeutics · 2020 · 36 citations · Full text

, , +17

Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma

Haiquan Lu, Yang Lü, Yangyiran Xie et al. · JCI Insight · 2019 · 34 citations · Full text

, , +17

1–5 of 13